Editorial Board — Medscape Neurology

Board Members

 

Board Member Details

Mark J. Alberts, MD
Mark J. Alberts, MD

Physician-in-chief, Ayer Neuroscience Institute, Hartford HealthCare; Chief, Department of Neurology, Hartford Hospital, Hartford, Connecticut

Mark J. Alberts, MD, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Genentech
Received income in an amount equal to or greater than $250 from: Genentech

Charles E. Argoff, MD
Charles E. Argoff, MD

Professor, Albany Medical College; Director, Comprehensive Pain Management Center, Albany Medical Center, Albany, New York

Charles E. Argoff, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Braeburn Pharmaceuticals; BioDelivery Sciences International, Inc.; Daiichi Sankyo, Inc.; Quest Diagnostics; Purdue Pharma L.P.; Depomed, Inc.; Kaleo; Teva; Novartis Pharmaceuticals Corporation; Pfizer, Inc.
Serve(d) as a speaker or a member of a speakers bureau for: Allergan, Inc.; BioDelivery Sciences International, Inc.; Amgen Inc.; Depomed, Inc.
Received research grant from: Grunenthal; Vortex

Hans-Christoph Diener, MD, PhD

Senior Professor for Clinical Neurosciences, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstrasse, Essen, Germany

Hans-Christoph Diener, MD, PhD, has disclosed the following relevant financial relationships:
Received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from: Abbott; Achelios; Addex Pharma; Alder; Allergan, Inc.; Almirall; Amgen; Autonomic Technology; Astra Zeneca Pharmaceuticals, LP; Bayer Vital; Berlin Chemie; Boehringer Ingelheim Pharmaceuticals; Bristol-Myers Squibb Company; CoAxia; Corimmun; Covidien; Daiichi-Sankyo; D-Pharm; Fresenius; Chordate; Coherex; CoLucid; Electrocore; GlaxoSmithKline; Grunenthal; Janssen-Cilag; Johnson & Johnson; Knoll; Labrys Biologics; Eli Lilly and Company; La Roche; 3M Medica; Medtronic; MindFrame; Menarini; Minster; Merck Sharp & Dohme Corp.; Neurobiological Technologies; Neuroscore; Novartis; Novo Nordisk; Paion; Parke-Davis; Pierre Fabre; Pfizer, Inc.; Portola; ; Schering-Plough; Servier; Solvay; Sygnis; Talecris; Thrombogenics; Schaper & Brummer; sanofi-aventis; St. Jude; Teva; WebMD Global; Wyeth; Weber & Weber; Yamanouchi
Received financial support for research projects from: Allergan; Almirall; AstraZeneca Pharmaceuticals, LP; Bayer; Electrocore; GlaxoSmithKline; Janssen-Cilag; Merck Sharp & Dohme Corp.; Pfizer, Inc.; Boehringer Ingelheim Pharmaceuticals; Lundbeck; Novartis; sanofi-aventis; Sygnis; Talecris
Headache research at the Department of Neurology in Essen is supported by: German Research Council (DFG); German Ministry of Education and Research (BMBF); European Union; National Institutes of Health; Bertelsmann Foundation; Heinz-Nixdorf Foundation
Serve(d) as editor of: Aktuelle Neurologie; Arzneimitteltherapie; Kopfschmerzen; Stroke News; Cephalalgia (co-editor)
Serve(d) on the editorial board for: Cephalalgia; Lancet Neurology; Stroke; European Neurology; Cerebrovascular Disorders
Chair of Clinical Guidelines Committee and Treatment Guidelines Committee for: German Society of Neurology
Contributed to European Heart Rhythm Association and European Society of Cardiology guidelines for treatment of atrial fibrillation

Randolph W. Evans, MD
Randolph W. Evans, MD

Clinical Professor, Baylor College of Medicine, Houston, Texas

Randolph W. Evans, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Alder; Amgen, Inc.; Eli Lilly and Company; Egalet; Novartis Pharmaceuticals Corporation
Serve(d) as a speaker or a member of a speakers bureau for: Allergan, Inc.; Depomed, Inc; electrocore; Amgen, Inc.; Novartis Pharmaceuticals Corporation; Promius Pharma
Received income in an amount equal to or greater than $250 from: Elsevier; Medlink Neurology; UpToDate

Mark Freedman, MD
Mark Freedman, MD

Mark S. Freedman, MSc, MD, Professor of Medicine (Neurology), University of Ottawa and The Ottawa Hospital Research Institute; Director, Multiple Sclerosis Research Unit, The Ottawa Hospital – General Campus, Ottawa, Ontario

Mark S. Freedman, MSc, MD, has disclosed the following relevant financial relationships:
Serve(d) as an advisor for: Actelion Pharmaceuticals, Ltd; Bayer HealthCare Pharmaceuticals; Biogen Idec Inc.; Clene Nanomedicine; EMD Inc.; Genzyme Corporation; F. Hoffman La-Roche Ltd; Merck & Co., Inc.; MedDay Pharmaceuticals; Novartis Pharmaceuticals Corporation; sanofi-aventis; Teva Pharmaceutical Industries
Serve(d) as a speaker or a member of a speakers bureau for: Genzyme Corporation
Received research and educational grants from: Genzyme Corporation
Received honoraria or consultation fees from: Actelion Pharmaceuticals, Ltd; Bayer HealthCare Pharmaceuticals; Biogen Idec Inc.; Chugai Pharma USA, LLC; Clene Nanomedicine; EMD Inc.; Genzyme Corporation; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; F. Hoffman La-Roche Ltd; sanofi-aventis; Teva Pharmaceutical Industries

Sam Gandy, MD, PhD
Sam Gandy, MD, PhD

Director, Center for Cognitive Health, Mount Sinai Hospital; Professor of Neurology and Psychiatry, Mount Sinai School of Medicine, New York, New York

Sam Gandy, MD, PhD, has disclosed the following relevant financial relationships:
Received a research grant from: Baxter; Amicus Therapeutics
Received income in an amount equal to or greater than $250 from: Pfizer Inc; DiaGenic

Werner Hacke, MD, PhD, DSc
Werner Hacke, MD, PhD

Senior Professor of Neurology, University of Heidelberg, Heidelberg, Germany

Werner Hacke, MD, PhD, DSc, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Boehringer Ingelheim Pharmaceuticals, Inc.; Neuravi; Bayer HealthCare Pharmaceuticals; Medtronic, Inc.
Received research grant from: Boehringer Ingelheim Pharmaceuticals, Inc.

Richard S. Isaacson, MD
Richard S. Isaacson, MD

Associate Professor, Department of Neurology, Weill Cornell Medicine, New York, New York

Richard S. Isaacson, has disclosed the following relevant financial relationships:
Serve(d) as a scientific advisor for: Accera, Inc

Helmi L. Lutsep, MD
Helmi L. Lutsep, MD

Professor and Vice Chair, Department of Neurology, Oregon Health & Science University; Chief of Neurology, VA Portland Health Care System, Portland, Oregon

Helmi L. Lutsep, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Stroke adjudication committee for CREST 2 trial and executive committee for DEFUSE 3 trial (National Institute of Neurological Disorders and Stroke)
Serve(d) on Physician Advisory Board for: Coherex Medical

Thomas Roth, PhD
Thomas Roth, PhD

Professor, Department of Psychiatry, Wayne State Medical School; Director, Sleep Disorders and Research Center, Henry Ford Hospital, Detroit, Michigan

Thomas Roth, PhD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Merck & Co., Inc.; Avadel Pharmaceuticals; Pfizer, Inc.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; Actelion Pharmacetuicals, Ltd; Jazz Pharmaceuticals, Inc.; Eisai, Inc.; Purdue Pharma L.P.
Serve(d) as a speaker or a member of the speakers bureau for: Merck & Co., Inc

Stephen D. Silberstein, MD
Stephen D. Silberstein, MD

Professor, Department of Neurology, University of Pennsylvania; Director, Jefferson Headache Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

Stephen D. Silberstein, MD, has disclosed the following relevant financial relationships:
Received honoraria for serving as a consultant and/or advisory panel member to: Alder Biopharmaceuticals; Allergan, Inc.; Amgen, Inc.; Avanir Pharmaceuticals, Inc.; Curelator, Inc.; Dr. Reddy’s Laboratories; eNeura Inc.; electroCore Medical, LLC; Lilly USA, LLC; Medscape, LLC; NINDS; Supernus Pharmaceuticals, Inc.; Teva Pharmaceuticals; Theranica; Trigemina, Inc.

Michael J. Thorpy, MD
Michael J. Thorpy, MD

Michael J. Thorpy, MD, Professor of Neurology, Albert Einstein College of Medicine; Director, Sleep-Wake Disorder Center, Montefiore Medical Center, Bronx, New York

Michael J. Thorpy, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Jazz Pharmaceuticals, Inc.; Harmony Biosciences
Serve(d) as a speaker or a member of a speakers bureau for: Jazz Pharmaceuticals, Inc.
Received research grant from: Jazz Pharmaceuticals, Inc.; Avadel Pharmaceuticals, Plc.; Harmony Biosciences; Balance

Andrew N. Wilner, MD
Andrew N. Wilner, MD

Associate Professor of Neurology, University of Tennessee Health Science Center, University of Tennessee; Staff Neurologist, Regional One Health, Memphis, Tennessee

Andrew N. Wilner, MD, has disclosed the following relevant financial relationships:
Serve(d) as Medical Advisor for: Accordant Health Services; CVS Health
Received income in an amount equal to or greater than $250 from: Neurology Times; Neurology Review; ReachMD.com; Accordant Health Services

читать далее ka4alka.com.ua

薬 ジェネリック

Супер камагра